Investors’ excitement over a breakup of Johnson & Johnson was somewhat muted on Friday, as eagerness to split a conglomerate ran into the disappointing recent record of Big Pharma spinoffs.

Johnson & Johnson (ticker: JNJ) said it would separate its consumer health division into a new company, leaving behind a pharmaceutical and medical-device business that it said would still be the largest healthcare company in the world.

The…

LEAVE A REPLY

Please enter your comment!
Please enter your name here